Host: Mimi Secor, DNP, FNP-BC, FAANP Guest: Maria Trent, MD, MPH, FAAP, FSAHM There are gaps in resources available to care for patients with mycoplasma genitalium (MGen). Since access to testing and to resistance testing are critical to be able to properly care for women suspected of having MGen, Dr. Mimi Secor talks with Dr. Maria Trent from Johns Hopkins School of Medicine about how clinicians can overcome common diagnostic and treatment challenges and shares guidelines updates from the CDC.

Women’s Health Update

Mycoplasma Genitalium: A Look at the Hidden STI & the Updated Guidelines

Host: Mimi Secor, DNP, FNP-BC, FAANP Guest: Maria Trent, MD, MPH, FAAP, FSAHM Dr. Mimi Secor is joined by Dr. Maria Trent to discuss mycoplasma genitalium (MGen), how we can better understand this infection and help reduce our patients' risk of it.

Key Considerations to Reach a Rapid MGen Diagnosis

Host: Mimi Secor, DNP, FNP-BC, FAANP Guest: Maria Trent, MD, MPH, FAAP, FSAHM Dr. Mimi Secor is joined by Dr. Maria Trent, Chief of the Division of Adolescent and Young Adult Medicine at Johns Hopkins School of Medicine, to discuss diagnosing and treating antibiotic resistant MGen.

Exploring Antibiotic Resistant MGen: A Look at Diagnosis & Treatment

Host: Charles Turck, PharmD, BCPS, BCCCP Guest: Paul Nyirjesy, MD Guest: Christina Muzny, MD Diagnosing vaginal infections early and accurately is key, but are current testing methods for vaginal infections facilitating early diagnosis? Joining Dr. Charles Turck to help answer this question are Drs. Christina Muzny and Paul Nirjesky, who share their multidisciplinary viewpoints on vaginal infections and diagnostic practices in women’s health.

Multidisciplinary Viewpoints in STI Testing: Clinical Revelations & Best Diagnostic Practices in Women’s Health

Guest: Barbara Van Der Pol, PhD, MPH Dr. Barbara Van Der Pol, a Professor of Medicine in Infectious Diseases at The University of Alabama at Birmingham and Scientist at the Center for Women’s Reproductive Health briefly discusses how rapid testing could impact the treatment landscape for sexually transmitted infections.

STI Rapid Testing: Why It's More Important Than Ever

Host: Prathima Setty, MD Issues of vaginal health are commonly seen in post-menopausal women, breast cancer survivors and women who have had a hysterectomy. According to the US Census Bureau there are nearly 46M women between the ages of 50 and 80, and over 2.8M breast cancer survivors. Existing treatments for post-menopause vaginal health can be time intensive or messy, or contraindicated for health reasons. They also can have numerous side-effects and offer only marginal improvement -- according to a doctor associated with the study. Host Dr. Prathima Setty welcomes Dr. Mickey Karram, Director of Fellowship Program on Female Pelvic Medicine & Reconstructive Surgery at The Christ Hospital, Cincinnati, OH. Dr. Karram will share preliminary findings from a trail evaluating laser treatment on post-menopausal women and breast cancer survivors experiencing vaginal health issues. Supported by an Educational Grant from BD Diagnostics. ReachMD retains full editorial control of the content for this program. 

Post-Menopause Vaginal Health Issues & Treatment

Welcome to the Women’s Health Update series, the latest edition of ReachMD’s Advances in Women’s Health. This series offers insight to improve gynecological care for women. Experts share evidence-based opinions on a variety of topics affecting your patients including: cervical cancer screening, abnormal uterine bleeding, management of preterm birth, and sexually transmitted infections.  Sponsored by:

hubhopper

Women’s Health Update

hubhopper